Comparison of 5-day, short-course gatifloxacin therapy with 7-day gatifloxacin therapy and 10-day clarithromycin therapy for acute exacerbation of chronic bronchitis

Clinical Therapeutics

Volumn 23, Issue 1, 2001, Pages 97-107

  Gotfried, Mark H ^a   DeAbate, C Andrew ^b   Fogarty, Charles ^c   Mathew, Chavaramplakic P ^d   Sokol, William N ^e  

^a Pulmonary Associates   (United States)

^b Medical Research Centers   (United States)

^c Pharmaceutical Research   (United States)

^d Westbank Research Centers   (United States)

^e Health Research Institute   (United States)

Author keywords

Acute exacerbations of chronic bronchitis; Clarithromycin; Gatifloxacin; Short course therapy

Indexed keywords

CLARITHROMYCIN; CORTICOSTEROID; GATIFLOXACIN;

ADULT; AGED; ARTICLE; CHRONIC BRONCHITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MULTICENTER STUDY; OUTCOMES RESEARCH; OUTPATIENT CARE; PATIENT COMPLIANCE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SMOKING; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0035147557     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(01)80033-3     Document Type: Article

References (31)

1. Acute infective exacerbations of chronic bronchitis
2. Treatment cost of acute exacerbations of chronic bronchitis
3. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis: Use of the protected specimen broth technique in 54 mechanically ventilated patients
4. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease
5. Antibiotics in chronic obstructive pulmonary disease exacerbations. A metaanalysis
6. Infectious exacerbations of chronic bronchitis: Diagnosis and management
7. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: Results of a national multicenter surveillance study
8. Clinical implications of resistance in the management of respiratory tract infections
9. The prevalence of drug resistant Streptococcus pneumoniae in Atlanta
10. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: Results of a 30-center national surveillance study
11. Confronting drug-resistant pneumococci
12. Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis
13. Gatifloxacin
14. Pharmacokinetics and pharmacodynamics of fluoroquinolones
15. Postantibiotic effects of gatifioxacin against gram-positive and -negative organisms
16. Efficacy and safety of gatifloxacin in the acute exacerbation of chronic bronchitis
17. Gatifloxacin versus cefuroxime axetil in patients with acute exacerbations of chronic bronchitis
18. Antibacterial activity of AM-1155 using an in vitro pharmacokinetic model
19. Activity of simulated oral dosing of gatifloxacin against Streptococcus pneumoniae in an in vitro dynamic model
20. Evaluation of new anti-infective drugs for the treatment of respiratory tract infections
21. Comparison of 5-day and 10-day cefixime in the treatment of acute exacerbation of chronic bronchitis
22. Comparison of the efficacy and safety of a short course of ceftibuten with that of amoxycillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis
23. Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis
24. Short-course cefuroxime axetil therapy in the treatment of acute bacterial exacerbations of chronic bronchitis
25. A double-blind, multicenter study of short-course once daily trovafloxacin vs. cefuroxime axetil in the treatment of acute bacterial exacerbations of chronic bronchitis
26. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis
27. Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract
28. Antibiotic noncompliance and waste in upper respiratory infections and acute diarrhea
29. Low dosage and long treatment duration of beta-lactam: Risk factors for carriage of penicillin-resistant Streptococcus pneumoniae